QSI • Support Levels: • $1.90–$1.95 is critical short-term support—break it, and price could dip to $1.75–$1.80. • Resistance Levels: • $2.07–$2.10 was the recent breakout zone—holding above that is bullish. • Next resistance is $2.25–$2.30, then the solid pivot at $2.40–$2.50. • Volume: • Today’s volume is moderate (~12M vs. ~10M average). No alarm bells yet, but watch if a bigger drop comes with a volume spike. • Indicators: • RSI dropped from overbought levels (~70) back to neutral (~55)—fresh potential for support if buyers step in. • MACD remains above zero but is flattening—a signal of slowing momentum.
QSI huge gap to be filled . Keep an eye on 2.15 - 2.73. And huge sell blocks in same zone. Interesting play. Could get short squeeze if market maker wishes too.
Chart Setup: Stock cleared both 50‑DMA ($1.47) and 200‑DMA ($1.38) in late May, recently pulling back to retest support. Today’s surge suggests potential new leg higher.
Key Levels: Support: $1.74 (recent swing low) and $1.84 short‑term stop offered by analysts . Resistance: Around $1.94; above that, next upside zone opens to $2.15 and then toward $2.40‑$2.50. Indicators: RSI is elevated (70+), indicating short‑term overbought risk. MACD is bullish, ATR confirms high volatility.
Takeaway: The setup is bullish but overbought, so a consolidation or pullback to $1.85–$1.90 before resuming uptrend would be healthy.
QSI is testing the upper boundary of its descending channel around $1.70, which aligns with the 78.6% Fib retracement from the recent swing. A clean break above $1.72 with volume could trigger a move toward $2.00, where heavy sell blocks are stacked.
Key levels to watch: • Breakout trigger: $1.72+ • Resistance zones: $2.00–$2.15, then $2.50 • Support: $1.60, $1.53 (200-day MA) • RSI: Neutral (~48), MACD turning slightly positive • Short interest: ~17% – potential for squeeze on breakout
If bulls reclaim $2.15, a run toward $2.50–$3.00 becomes more likely, though that zone has heavy supply. Watching volume closely.
QSI so the universe giving us a chance to load up. Thanks to the Feud. Elon vs President.
Whoever follows me, DCA your open position to get better exit. And buy some good momentum stocks. We can exit by next week to make good money. Both big boys will eventually settle. Market will be green
1. First-Mover in Protein Sequencing • QSI is aiming to do for proteins what Illumina did for DNA. • Their Sapphire platform can potentially democratize proteomics by making it faster, cheaper, and more accessible. 2. Massive Market Opportunity • The proteomics market is expected to reach ~$80B by 2030. • Drug development, diagnostics, and personalized medicine all rely increasingly on protein-level data. 3. Platform Play, Not a One-Off Product • If successful, QSI could become a core platform in labs like Thermo Fisher or Illumina—leading to high-margin recurring revenue. 4. Tech Validation by Former Illumina Founder • Jonathan Rothberg, who founded Illumina and Butterfly Network, is behind QSI. His track record brings credibility.
QSI • Support Levels: